Sucampo Pharmaceuticals, Inc. Appoints Kei Tolliver to Board of Directors

Published: May 29, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (“Sucampo”) today announced that Kei S. Tolliver, executive vice president at S&R Technology Holdings, LLC, was elected to its board of directors at the annual shareholder meeting on May 22, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news